Citation Impact
Citing Papers
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
2011 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
SharedPseudomonas aeruginosagenotypes are common in Australian cystic fibrosis centres
2012
Cystic fibrosis: the mechanisms of pathogenesis of an inherited lung disorder
2007
Mucolytics in cystic fibrosis
2007
Mucociliary Clearance as an Outcome Measure for Cystic Fibrosis Clinical Research
2007
Recent advances in cystic fibrosis
2008
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
2011
Cystic fibrosis: a disease of vulnerability to airway surface dehydration
2007
Cystic fibrosis
2016 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
Natural products: An evolving role in future drug discovery
2011 Standout
A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
2014
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
2003 Standout
Cystic Fibrosis Therapeutics
2013
Managing Cystic Fibrosis
2011
Mucus Clearance and Lung Function in Cystic Fibrosis with Hypertonic Saline
2006
Clinical trials in cystic fibrosis
2007
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Denufosol: A review of studies with inhaled P2Y2 agonists that led to Phase 3
2008
Perceptions of barriers and facilitators: Self-management decisions by older adolescents and adults with CF
2010
Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis
2009
Quorum sensing signal–response systems in Gram-negative bacteria
2016 Standout
Cystic Fibrosis Pulmonary Guidelines
2007
Longitudinal association between medication adherence and lung health in people with cystic fibrosis
2011
Hypertonic Saline Therapy in Cystic Fibrosis
2006
Emerging Treatments in Cystic Fibrosis
2009
Pharmacotherapy of impaired mucociliary clearance in non‐CF pediatric lung disease. A review of the literature
2007
Chronic Inflammation in the Cystic Fibrosis Lung: Alterations in Inter- and Intracellular Signaling
2007
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Mucociliary clearance in cystic fibrosis
2002
Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication
2003
Antimicrobial activity of metals: mechanisms, molecular targets and applications
2013 Standout
Contemporary Review on Spontaneous Coronary Artery Dissection
2016
Phase 2 Randomized Safety and Efficacy Trial of Nebulized Denufosol Tetrasodium in Cystic Fibrosis
2007
Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
2010
New Perspectives on Innovative Drug Discovery: An Overview
2010
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Efficacy and Safety of Inhaled Aztreonam Lysine for Airway Pseudomonas in Cystic Fibrosis
2009
Prospective evaluation of emerging bacteria in cystic fibrosis
2005
Adult Cystic Fibrosis
2007
Cystic Fibrosis Pulmonary Guidelines
2013
Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis
2013
Evidence for airway surface dehydration as the initiating event in CF airway disease
2007
AMPK Agonists Ameliorate Sodium and Fluid Transport and Inflammation in Cystic Fibrosis Airway Epithelial Cells
2009
Cystic Fibrosis: Pathogenesis and Future Treatment Strategies
2009
Therapy of CF-Patients with Amitriptyline and Placebo - a Randomised, Double-Blind, Placebo-Controlled Phase IIb Multicenter, Cohort-Study
2013 Standout
Airway Mucus Function and Dysfunction
2010 Standout
Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders
2008
Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis
2009
End of life care for patients with cystic fibrosis
2011
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
Indicators of pulmonary exacerbation in cystic fibrosis: A Delphi survey of patients and health professionals
2014
Front-runners for pharmacotherapeutic correction of the airway ion transport defect in cystic fibrosis
2008
Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia
2010
Inhalation of Moli1901 in Patients With Cystic Fibrosis
2007
Hypertonic Saline Is Effective in the Prevention and Treatment of Mucus Obstruction, but Not Airway Inflammation, in Mice with Chronic Obstructive Lung Disease
2013
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Historical Perspective of Traditional Indigenous Medical Practices: The Current Renaissance and Conservation of Herbal Resources
2014 Standout
QUORUM SENSING: Cell-to-Cell Communication in Bacteria
2005 Standout
Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration
2011
Oxadiazoles in Medicinal Chemistry
2011 Standout
Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement From the American Heart Association
2018
BRONCHIAL THERMOPLASTY IMPROVES ASTHMA STATUS OF MODERATE-TO-SEVERE PERSISTENT ASTHMATICS OVER AND ABOVE CURRENT STANDARD-OF-CARE
2006
Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
2014 Standout
Nebulised hypertonic saline for cystic fibrosis
2018
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Spontaneous coronary artery dissection
2017
Nebulized Hypertonic Saline for Bronchiolitis in the Emergency Department
2014
In Vitro Activities of a Novel Nanoemulsion against Burkholderia and Other Multidrug-Resistant Cystic Fibrosis-Associated Bacterial Species
2008
Works of C. Moriarty being referenced
Effect of Burkholderia cepacia infection in the clinical course of patients with cystic fibrosis: A pilot study in a Sydney clinic
2002
Clinical profile of adult cystic fibrosis patients with frequent epidemic clones of Pseudomonas aeruginosa
2010
Recombinant Activated Factor VII for Massive Hemoptysis in Patients With Cystic Fibrosis
2009
Spontaneous coronary artery dissection associated with coughing
2013
Improved outcomes of patients with cystic fibrosis admitted to the intensive care unit
2004
A Controlled Trial of Long-Term Inhaled Hypertonic Saline in Patients with Cystic Fibrosis
2006
504 Three methods of monitoring adherence in a long-term trial in Cystic Fibrosis
2006
Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis
2000